Cellavision

We feel like a SITTING DUCK on the markets.

CEVI.ST US4 (ISIN: SE0000683484)      

CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education.

Market: Stockholm

http://www.cellavision.com

Fair value: 145 SEK
Discount: 22%

Average yearly return: 48%

Outperformer

On February 7, 2017
Cellavision AB announced : * Q4 net sales 72.8 million Swedish crowns versus 61.6 million crowns year ago
* Q4 operating profit 21.6 million crowns versus 16.4 million crowns year ago

* Proposes 2016 dividend of 1.50 crowns per share